KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biocryst Pharmaceuticals (BCRX) Return on Capital Employed (2023 - 2025)

Biocryst Pharmaceuticals (BCRX) has disclosed Return on Capital Employed for 8 consecutive years, with 0.1% as the latest value for Q1 2025.

  • For the quarter ending Q1 2025, Return on Capital Employed rose 37.0% year-over-year to 0.1%, compared with a TTM value of 0.1% through Mar 2025, up 37.0%, and an annual FY2024 reading of 0.01%, changed N/A over the prior year.
  • Return on Capital Employed was 0.1% for Q1 2025 at Biocryst Pharmaceuticals, up from 0.01% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.1% in Q1 2025 and bottomed at 0.29% in Q2 2024.
  • Average Return on Capital Employed over 3 years is 0.17%, with a median of 0.26% recorded in 2024.
  • The sharpest move saw Return on Capital Employed rose 27bps in 2024, then skyrocketed 37bps in 2025.
  • Year by year, Return on Capital Employed stood at 0.28% in 2023, then soared by 97bps to 0.01% in 2024, then skyrocketed by 1348bps to 0.1% in 2025.
  • Business Quant data shows Return on Capital Employed for BCRX at 0.1% in Q1 2025, 0.01% in Q4 2024, and 0.24% in Q3 2024.